Page last updated: 2024-10-21

menthol and Headache

menthol has been researched along with Headache in 4 studies

Menthol: A monoterpene cyclohexanol produced from mint oils.

Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"The objective of this study was to determine associations between cigarette smoking and the existence of headache in a nationally representative sample, with attention to differences in effect estimates between mentholated and non-mentholated cigarettes smoking."7.83Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample. ( Estus, S; Gan, WQ; Smith, JH, 2016)
"The objective of this study was to determine associations between cigarette smoking and the existence of headache in a nationally representative sample, with attention to differences in effect estimates between mentholated and non-mentholated cigarettes smoking."3.83Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample. ( Estus, S; Gan, WQ; Smith, JH, 2016)
"The mean migraine duration was 18."3.11A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study. ( Arkuszewski, M; Ecochard, L; Kim, BK; Li, Z; Lian, Y; Su, W; Wan, Q; Wang, H; Wang, SJ; Wen, S; Yin, F; Yu, S; Yu, T; Zhou, J, 2022)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Yu, S3
Kim, BK3
Wang, H3
Zhou, J3
Wan, Q3
Yu, T3
Lian, Y3
Arkuszewski, M3
Ecochard, L3
Wen, S3
Yin, F3
Li, Z3
Su, W3
Wang, SJ3
D'Ruiz, CD1
Graff, DW1
Yan, XS1
Gan, WQ1
Estus, S1
Smith, JH1
PAPA, CM1
SHELLEY, WB1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Characterization of Nicotine Exposure and Urge-to-Smoke Following a Single Controlled Administration and Short-Term Ad Lib Use of Electronic Cigarettes and Conventional Cigarettes in Adult Smokers[NCT02210754]24 participants (Actual)Interventional2014-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for menthol and Headache

ArticleYear
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study.
    The journal of headache and pain, 2022, Nov-21, Volume: 23, Issue:1

    Topics: Acute Pain; Antibodies, Monoclonal, Humanized; Asia; Camphor; Female; Headache; Humans; Male; Mentho

2022
Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes.
    BMC public health, 2015, Sep-30, Volume: 15

    Topics: Adult; Cough; Craving; Cross-Over Studies; Dizziness; Electronic Nicotine Delivery Systems; Female;

2015

Other Studies

2 other studies available for menthol and Headache

ArticleYear
Association Between Overall and Mentholated Cigarette Smoking With Headache in a Nationally Representative Sample.
    Headache, 2016, Volume: 56, Issue:3

    Topics: Adult; Cross-Sectional Studies; Female; Headache; Humans; Male; Menthol; Middle Aged; Nutrition Surv

2016
MENTHOL HYPERSENSITIVITY; DIAGNOSTIC BASOPHIL RESPONSE IN A PATIENT WITH CHRONIC URTICARIA, FLUSHING, AND HEADACHES.
    JAMA, 1964, Aug-17, Volume: 189

    Topics: Basophils; Dentifrices; Drug Hypersensitivity; Headache; Humans; Hypersensitivity; Leukocyte Count;

1964